(MENAFN- GlobeNewsWire - Nasdaq) Rising Chronic Disease Burden, Biosimilar Insulin Adoption, and Smart Connected Pen Technologies Drive Sustained Market Expansion. Austin, United States, March 12, ...
A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...
The global injection pen market is set to witness a growth rate of 7% in the next 5 years. Rising prevalence of chronic diseases, patient convenience and ease of use, technological advancements, ...
For people who require insulin therapy, staying on top of multiple daily injections and getting the dosages right can be an overwhelming task. Insulin pens can make diabetes management easier, and ...
So why did I decide to try the buzzy NAD+ injection pen when I favour a food-first approach and lifestyle tweaks over a cabinet full of pills? Well, there are times when even the most balanced of ...
Owen Mumford has released a new injection pen training video. Developed in collaboration with consultant pharmacists and nursing professionals, the video addresses critical steps when clinically ...
Anavip contains venom-specific F(ab’)2 fragments of immunoglobulin G that bind and neutralize venom toxins. Novo Nordisk announced the availability of Ozempic (semaglutide) injection 1mg as a single ...
The global injection pen market is expected to grow at a rate of 7% over the next five years. Key factors fueling this growth include the rising prevalence of chronic diseases, the increasing demand ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved somatropin pre-filled injection pens for the treatment of children and adults with growth ...
Dublin, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The "Injection Pen Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's ...
The U.S. Injection Pen Market has been valued at USD 29.76 Billion in 2025 and is expected to reach USD 60.61 Billion by 2035, growing at an estimated CAGR of 7.35% from 2026 to 2035. The prevalence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results